West Pharmaceutical Services Inc. (WST), while reporting higher first-quarter earnings and sales, on Thursday issued positive second-quarter outlook, and lifted fiscal 2026 view.
In pre-market activity, the shares were gaining around 18.1 percent, trading at $324.00.
Looking ahead for the second quarter, the company projects adjusted earnings per share in the range of $2.05 to $2.12, up 11.4 percent to 15.2 percent from last year. Net sales are expected to be $830 million to $850 million, a growth of 8.3 percent to 10.9 percent year-over-year. Organic net sales growth is expected to be in the range of 7.0 percent to 9.6 percent.
Further, for fiscal 2026, West Pharma now projects adjusted earnings per share in the range of $8.40 to $8.75, up from the previous range of $7.85 to $8.20.
Full-year 2026 net sales guidance has been increased to a range of $3.295 billion to $3.350 billion from previous view of $3.215 billion to $3.275 billion.
Reported net sales growth is now anticipated to be in the range of 7.2 percent to 9.0 percent, and organic net sales growth is expected to be in the range of 7 percent to 9 percent.
In the first quarter, the company's net earnings came in at $138.8 million, compared to $89.8 million last year. Earnings per share climbed 56.1 percent to $1.92 from prior year's $1.23.
Adjusted earnings were $154.3 million or $2.13 per share for the period, compared to $106.2 million or $1.45 per share a year ago.
The company's net sales for the period rose 21.0 percent to $844.9 million from $698.0 million last year. Organic net sales growth was 15.3 percent, driven by High Value Products Components business with double-digit growth in both GLP-1 and non-GLP-1 revenues.
West Pharma attributed the better-than-expected performance to continued market demand and the team's outstanding efforts in ramping up production, especially in Europe.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.